NVNO: enVVeno Medical Corporation Stock

by  •  • Comments Off on NVNO: enVVeno Medical Corporation Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 65.52
Enterprise Value ($M) 63.20
Book Value ($M) 42.37
Book Value / Share 3.18
Price / Book 1.55
NCAV ($M) 40.79
NCAV / Share 3.06
Price / NCAV 1.61

Profitability (mra)
Return on Invested Capital (ROIC) -0.51
Return on Assets (ROA) -0.60
Return on Equity (ROE) -0.65

Liquidity (mrq)
Quick Ratio 29.08
Current Ratio 29.08

Balance Sheet (mrq) ($M)
Current Assets 43.25
Assets 44.83
Liabilities 2.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -25.24
Net Income -23.52
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -18.86
Cash from Investing -7.87
Cash from Financing 25.79

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-23 13G/A Perceptive Advisors Llc 9.90 0.00
02-14 13G Nantahala Capital Management, LLC 9.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT UNDER SECTIO
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13
2023-10-26 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT UNDER SE
2023-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT UNDER SECTION

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-14 3,294 1,035 318.26
2024-05-13 1,516 35,533 4.27
2024-05-10 9,858 75,547 13.05
2024-05-09 3,596 5,225 68.82

(click for more detail)

Similar Companies
NTRB – Nutriband Inc. NURO – NeuroMetrix, Inc.
NUWE – Nuwellis, Inc. NXGL – NEXGEL, Inc.
NXL – Nexalin Technology, Inc.


Financial data and stock pages provided by
Fintel.io